Future Pak表示,其最新报价的总对价为每股11.62美元至12.12美元。如果全部行使cvr,相对于万达5月6日4.84美元的收盘价,也有140%至150%的溢价。据Future Pak称,c...查看全文
万达生物制药(VNDA)03-07 05:55
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027249 Size: 7 KB 网页链接查看全文
万达生物制药(VNDA)04-18 05:25
$万达生物制药(VNDA)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001193125-24-099251 Act: 34 Size: 691 KB 网页链接查看全文
万达生物制药(VNDA)05-10 05:25
$万达生物制药(VNDA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-135393 Act: 34 Size: 822 KB 网页链接查看全文
万达生物制药(VNDA)03-07 05:55
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027253 Size: 8 KB 网页链接查看全文
万达生物制药(VNDA)05-04 04:05
$万达生物制药(VNDA)$ 8-K Current report, items 1.01, 3.03, and 9.01 Accession Number: 0001193125-24-130668 Act: 34 Size: 209 KB 网页链接查看全文
万达生物制药(VNDA)05-04 04:35
$万达生物制药(VNDA)$ 8-A12B/A [Amend] Registration of securities [Section 12(b)] Accession Number: 0001193125-24-130778 Act: 34 Size: 19 KB 网页链接查看全文
万达生物制药(VNDA)05-09 04:15
$万达生物制药(VNDA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-021658 Act: 34 Size: 415 KB 网页链接查看全文
万达生物制药(VNDA)04-30 04:35
$万达生物制药(VNDA)$ ARS/A [Amend] Annual Report to Security Holders Accession Number: 0001213900-24-037204 Act: 34 Size: 766 KB 网页链接查看全文
万达生物制药(VNDA)05-22 05:05
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063022 Size: 7 KB 网页链接查看全文
BT美股手纪2014-02-13 08:58
$Vanda Pharmaceuticals(VNDA)$ 这个股明天盘前预报,OPTION TRADING 预示要到15,可惜今天忘记了,下午有事只好错过了。查看全文
薛定谔的狐米2013-12-05 09:54
对@Elsala 说:$Vanda Pharmaceuticals(VNDA)$ $阿卡迪亚(ACAD)$ 和$PDL BioPharma(PDLI)$ 有啥观点啊?^^查看全文
$万达生物制药(VNDA)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001628280-24-025254 Act: 34 Size: 283 KB 网页链接
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-064669 Size: 7 KB 网页链接
$万达生物制药(VNDA)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001628280-24-025241 Act: 34 Size: 216 KB 网页链接
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063022 Size: 7 KB 网页链接
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063015 Size: 7 KB 网页链接
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063017 Size: 7 KB 网页链接
$万达生物制药(VNDA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063019 Size: 6 KB 网页链接
$万达生物制药(VNDA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001628280-24-024550 Act: 33 Size: 484 KB 网页链接
$万达生物制药(VNDA)$ 8-K Current report, item 5.07 Accession Number: 0001628280-24-024405 Act: 34 Size: 222 KB 网页链接
$万达生物制药(VNDA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-137238 Act: 34 Size: 24 KB 网页链接